Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma

Human Genetics

Volumn 114, Issue 2, 2004, Pages 207-210

  Al Tassan, Nada ^a   Eisen, Tim ^b   Maynard, Julie ^a   Bridle, Helen ^b   Shah, Bindiya ^b   Fleischmann, Christina ^b   Sampson, Julian R ^a   Cheadle, Jeremy P ^a   Houlston, Richard S ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHERITANCE; INTRON; LUNG CANCER; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MYH GENE; PRIORITY JOURNAL; RISK FACTOR;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA, NEOPLASM; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTORS; VARIATION (GENETICS);

EID: 1042304289     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-1033-2     Document Type: Article

References (10)

1. Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR, Cheadle JP (2002) Inherited variants of MYH associated with somatic G:C→T: A mutations in colorectal tumors. - Nat Genet 30:227-232
2. Fleiss JL, Tytun A, Uray HK (1980) A simple approximation for calculating sample sizes for comparing independent proportions. - Biometrics 36:343-346
3. Hussain SP, Harris CC (1999) p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 428:23-32
4. Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, Sampson JR, Cheadle JP (2002) Biallelic germline mutations in MYH predispose of multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961-2967
5. LeMarchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11:409-412
6. Michaels ML, Miller JH (1992) The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine). J Bacteriol 174:6321-6325
7. Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, Frayling I, Jordan S, Maher ER, Mak T, Maynard J, Pigatto F, Shaw J, Cheadle JP (2003) Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362:37-41
8. Shinmura K, Yamaguchi S, Saitoh T, Kohno T, Yokota J (2001) Somatic mutations and the single nucleotide polymorphisms of base excision repair genes involved in the repair of 8-hydroxyguanine in damaged DNA. Cancer Lett 166:65-69
9. Shopland DR, Eyre HJ, Pechacek TF (1991) Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83:1142-1148
10. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1521